Cell & Gene Therapy - Turning Human Fat into Insulin-Producing Organoids That Reverse Diabetes
View as a Web Page
News Medical
 
  Cell & Gene Therapy Cell & Gene Therapy logo  
  The latest stem cells news from News Medical  
 

Event guide: 9th Gene Therapy Development Summit 2026Event guide: 9th Gene Therapy Development Summit 2026

Gene therapy is back in the fast lane. With tough questions around delivery, vector design, redosing, analytics, and scale-up, the 9th Gene Therapy Development Summit 2026 is the deep dive the field needs.

Download Now
 
   Turning Human Fat into Insulin-Producing Organoids That Reverse DiabetesTurning Human Fat into Insulin-Producing Organoids That Reverse Diabetes
 
By preserving fat tissue architecture, researchers created organoids that restore insulin function, paving the way for advancements in diabetes treatment.
 
   Advances in hemophilia gene therapy bring hope for pediatric patientsAdvances in hemophilia gene therapy bring hope for pediatric patients
 
In the past three years, gene therapy has reshaped what's possible in hemophilia treatment for patients 18 and older. But a key question remains: How soon will these advances reach children?
 
 Advancing stem cell regeneration through animal-free culture systems
 
Advancing stem cell regeneration through animal-free culture systemsIntestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection.
 
 
 Gene therapy breakthrough could provide hope for millions living with chronic pain
 
Gene therapy breakthrough could provide hope for millions living with chronic painA preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of addiction from narcotics treatments, a breakthrough which could provide hope for the more than 50 million Americans living with chronic pain.
 
 
 Researchers provide a global catalog of human pluripotent stem cell lines for clinical use
 
Researchers provide a global catalog of human pluripotent stem cell lines for clinical useTo date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have entered early developmental pipelines.
 
 
 CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment
 
CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatmentGenetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid deposits of misfolded transthyretin (TTR) proteins.
 
 
 UBC researchers crack code to grow helper t cells from stem cells
 
UBC researchers crack code to grow helper t cells from stem cellsFor the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a controlled laboratory setting.
 
 
 Scientists discover how stem cells navigate and repair brain damage after stroke
 
Scientists discover how stem cells navigate and repair brain damage after strokeSome parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye-called the cornea-can heal from minor scratches within a single day.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026